Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiulong Biochemicals appears to be a Chinese manufacturer of heparin-related active pharmaceutical ingredients rather than a therapeutic drug developer. Publicly accessible information is sparse, but multiple industry market reports list the company among global suppliers of heparin and heparin sodium API, indicating commercial participation in the anticoagulant supply chain. The business seems focused on manufacturing and supplying heparin raw materials used in unfractionated heparin and low-molecular-weight heparin products. There is no clear evidence from readily available sources of an innovative clinical pipeline, proprietary drug-development platform, or disclosed partnered therapeutic programs. The company should therefore be viewed primarily as a commercial heparin/API supplier in the broader pharma and healthcare manufacturing ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiulong Biochemicals.